EZZ Life Science Director’s Holdings Update

EZZ Life Science Holdings Ltd. (AU:EZZ) has released an update.

EZZ Life Science Holdings Ltd. has reported a change in the holdings of director Glenn Walter Cross, who now possesses an additional 15,000 performance rights on top of his direct and indirect shareholdings. The performance rights were issued under the company’s employee share plan and are valued at $0.08 each. This change occurs without any alteration in the number of ordinary shares held, which remains at 40,000 directly and 26,000 indirectly through his spouse Penelope Marshall.

For further insights into AU:EZZ stock, check out TipRanks’ Stock Analysis page.